LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Education
• Health & Fitness
• Non-Profit & Charity

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

cancer, article, prostate, google, scholar, pubmed, research, cas, ccl, metastatic, patients, clin, study, carlumab, castrationresistant, janssen, johnson, phase, human, cnto, pienta, bono, received, pain, oncol, privacy, cookies, content, data, monoclonal, antibody, ligand, puchalski, tumor, access, prednisone, res, development, usa, publish, search, ccchemokine, august, kenneth, schrijvers, takimoto, growth, docetaxel, response, bone,

Topics {✒️}

randomised open-label trial month download article/chapter cc-chemokine ligand 2 steady-state serum concentrations 10-μg/ml target concentration 15 mg/kg carlumab q2w pthrp-induced mcp-1 production metastatic prostate cancer consultant/advisory board member jean-pascal machiels progressive prostate cancer advanced prostate cancer prostate cancer growth open-label study prostate cancer progression randomized controlled trial full article pdf monocyte chemotactic protein-1 promotes tumor growth privacy choices/manage cookies received research grants offer clinical benefit related subjects autocrine factor human monoclonal antibody targeting ccl2 de bono ccr2 expression correlates metastatic bone disease patient developed antibodies prostate cancer single agent cancer research human igg1κ mab check access instant access article investigational european economic area secondary endpoints included spinal cord compression show antitumor activity prostatic hyperplasia destructive cascade mediated world health organization nhs foundation trust conditions privacy policy ccl2/ccr2 axis response evaluation criteria accepting optional cookies shobha seetharam

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
         description: Background CC-chemokine ligand 2 (CCL2) promotes tumor growth by angiogenesis, macrophage infiltration and tumor invasion, and distant metastasis. Carlumab (CNTO 888) is a human IgG1κ mAb with high affinity and specificity for human CCL2. Preclinical data suggest carlumab may offer clinical benefit to cancer patients. Methods In a phase 2, open-label study, patients with metastatic castration-resistant prostate cancer (CRPC) previously treated with docetaxel received a 90-min infusion of 15 mg/kg carlumab q2w. The primary endpoint was response rate: change from baseline in skeletal lesions, extraskeletal lesions, and PSA values. Secondary endpoints included overall response rate (CR + PR) by RECIST, OS, PSA response, safety, pharmacodynamics, pharmacokinetics, immunogenicity. Results Forty-six patients were treated with 6 median (range 1, 26) doses. One patient had SD >6 months. There were no PSA or RECIST responses. Fourteen (34 %) patients had SD ≥3 months. Median OS was 10.2 (95 % CI: 5.2, not estimable) months. Twelve (39 %) patients reported improved pain scores. AEs occurred in 43 (93 %) patients, including 27 (59 %) with grade ≥3 AEs. Common grade ≥3 AEs were back (11 %) and bone (9 %) pain. Twenty (43 %) patients experienced SAEs, including pneumonia, spinal cord compression, back pain. No patient developed antibodies to carlumab. Steady-state serum concentrations were achieved after 3 repeated doses and were above the 10-μg/mL target concentration. Suppression of free CCL2 serum concentrations was briefly observed following each dose but was not sustained. Conclusion Carlumab was well-tolerated but did not block the CCL2/CCR2 axis or show antitumor activity as a single agent in metastatic CRPC.
         datePublished:2012-08-21T00:00:00Z
         dateModified:2012-08-21T00:00:00Z
         pageStart:760
         pageEnd:768
         sameAs:https://doi.org/10.1007/s10637-012-9869-8
         keywords:
            Prostatic neoplasms
            CC chemokine ligand 2
            Carlumab
            CC chemokine receptor 2
            Oncology
            Pharmacology/Toxicology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10637-012-9869-8/MediaObjects/10637_2012_9869_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10637-012-9869-8/MediaObjects/10637_2012_9869_Fig2_HTML.gif
         isPartOf:
            name:Investigational New Drugs
            issn:
               1573-0646
               0167-6997
            volumeNumber:31
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Kenneth J. Pienta
               affiliation:
                     name:University of Michigan Comprehensive Cancer Center
                     address:
                        name:University of Michigan Comprehensive Cancer Center, Ann Arbor, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Jean-Pascal Machiels
               affiliation:
                     name:Université catholique de Louvain
                     address:
                        name:Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dirk Schrijvers
               affiliation:
                     name:Ziekenhuisnetwerk Antwerpen-Middelheim
                     address:
                        name:Ziekenhuisnetwerk Antwerpen-Middelheim, Antwerp, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Boris Alekseev
               affiliation:
                     name:FGU Hertzen Oncology Research Institute of Rosmedtechnology
                     address:
                        name:FGU Hertzen Oncology Research Institute of Rosmedtechnology, Moscow, Russia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mikhail Shkolnik
               affiliation:
                     name:Federal Agency for High Technology Medical Care
                     address:
                        name:Russian Scientific Center of Radiology and Surgical Technologies, Federal Agency for High Technology Medical Care, St. Petersburg, Russia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Simon J. Crabb
               affiliation:
                     name:University of Southampton Faculty of Medicine
                     address:
                        name:University of Southampton Faculty of Medicine, Southampton, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Susan Li
               affiliation:
                     name:Janssen Research & Development
                     address:
                        name:Janssen Research & Development, Spring House, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shobha Seetharam
               affiliation:
                     name:Janssen Research & Development
                     address:
                        name:Janssen Research & Development, Radnor, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Thomas A. Puchalski
               affiliation:
                     name:Janssen Research & Development
                     address:
                        name:Janssen Research & Development, Spring House, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chris Takimoto
               affiliation:
                     name:Janssen Research & Development
                     address:
                        name:Janssen Research & Development, Radnor, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yusri Elsayed
               affiliation:
                     name:Janssen Research & Development
                     address:
                        name:Janssen Research & Development, Raritan, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Fitzroy Dawkins
               affiliation:
                     name:Janssen Research & Development
                     address:
                        name:Janssen Research & Development, Raritan, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Johann S. de Bono
               affiliation:
                     name:NHS Foundation Trust and the Institute of Cancer Research
                     address:
                        name:Royal Marsden, NHS Foundation Trust and the Institute of Cancer Research, Sutton, UK
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
      description: Background CC-chemokine ligand 2 (CCL2) promotes tumor growth by angiogenesis, macrophage infiltration and tumor invasion, and distant metastasis. Carlumab (CNTO 888) is a human IgG1κ mAb with high affinity and specificity for human CCL2. Preclinical data suggest carlumab may offer clinical benefit to cancer patients. Methods In a phase 2, open-label study, patients with metastatic castration-resistant prostate cancer (CRPC) previously treated with docetaxel received a 90-min infusion of 15 mg/kg carlumab q2w. The primary endpoint was response rate: change from baseline in skeletal lesions, extraskeletal lesions, and PSA values. Secondary endpoints included overall response rate (CR + PR) by RECIST, OS, PSA response, safety, pharmacodynamics, pharmacokinetics, immunogenicity. Results Forty-six patients were treated with 6 median (range 1, 26) doses. One patient had SD >6 months. There were no PSA or RECIST responses. Fourteen (34 %) patients had SD ≥3 months. Median OS was 10.2 (95 % CI: 5.2, not estimable) months. Twelve (39 %) patients reported improved pain scores. AEs occurred in 43 (93 %) patients, including 27 (59 %) with grade ≥3 AEs. Common grade ≥3 AEs were back (11 %) and bone (9 %) pain. Twenty (43 %) patients experienced SAEs, including pneumonia, spinal cord compression, back pain. No patient developed antibodies to carlumab. Steady-state serum concentrations were achieved after 3 repeated doses and were above the 10-μg/mL target concentration. Suppression of free CCL2 serum concentrations was briefly observed following each dose but was not sustained. Conclusion Carlumab was well-tolerated but did not block the CCL2/CCR2 axis or show antitumor activity as a single agent in metastatic CRPC.
      datePublished:2012-08-21T00:00:00Z
      dateModified:2012-08-21T00:00:00Z
      pageStart:760
      pageEnd:768
      sameAs:https://doi.org/10.1007/s10637-012-9869-8
      keywords:
         Prostatic neoplasms
         CC chemokine ligand 2
         Carlumab
         CC chemokine receptor 2
         Oncology
         Pharmacology/Toxicology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10637-012-9869-8/MediaObjects/10637_2012_9869_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10637-012-9869-8/MediaObjects/10637_2012_9869_Fig2_HTML.gif
      isPartOf:
         name:Investigational New Drugs
         issn:
            1573-0646
            0167-6997
         volumeNumber:31
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Kenneth J. Pienta
            affiliation:
                  name:University of Michigan Comprehensive Cancer Center
                  address:
                     name:University of Michigan Comprehensive Cancer Center, Ann Arbor, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Jean-Pascal Machiels
            affiliation:
                  name:Université catholique de Louvain
                  address:
                     name:Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dirk Schrijvers
            affiliation:
                  name:Ziekenhuisnetwerk Antwerpen-Middelheim
                  address:
                     name:Ziekenhuisnetwerk Antwerpen-Middelheim, Antwerp, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Boris Alekseev
            affiliation:
                  name:FGU Hertzen Oncology Research Institute of Rosmedtechnology
                  address:
                     name:FGU Hertzen Oncology Research Institute of Rosmedtechnology, Moscow, Russia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mikhail Shkolnik
            affiliation:
                  name:Federal Agency for High Technology Medical Care
                  address:
                     name:Russian Scientific Center of Radiology and Surgical Technologies, Federal Agency for High Technology Medical Care, St. Petersburg, Russia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Simon J. Crabb
            affiliation:
                  name:University of Southampton Faculty of Medicine
                  address:
                     name:University of Southampton Faculty of Medicine, Southampton, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Susan Li
            affiliation:
                  name:Janssen Research & Development
                  address:
                     name:Janssen Research & Development, Spring House, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shobha Seetharam
            affiliation:
                  name:Janssen Research & Development
                  address:
                     name:Janssen Research & Development, Radnor, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Thomas A. Puchalski
            affiliation:
                  name:Janssen Research & Development
                  address:
                     name:Janssen Research & Development, Spring House, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chris Takimoto
            affiliation:
                  name:Janssen Research & Development
                  address:
                     name:Janssen Research & Development, Radnor, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yusri Elsayed
            affiliation:
                  name:Janssen Research & Development
                  address:
                     name:Janssen Research & Development, Raritan, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Fitzroy Dawkins
            affiliation:
                  name:Janssen Research & Development
                  address:
                     name:Janssen Research & Development, Raritan, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Johann S. de Bono
            affiliation:
                  name:NHS Foundation Trust and the Institute of Cancer Research
                  address:
                     name:Royal Marsden, NHS Foundation Trust and the Institute of Cancer Research, Sutton, UK
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Investigational New Drugs
      issn:
         1573-0646
         0167-6997
      volumeNumber:31
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Michigan Comprehensive Cancer Center
      address:
         name:University of Michigan Comprehensive Cancer Center, Ann Arbor, USA
         type:PostalAddress
      name:Université catholique de Louvain
      address:
         name:Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium
         type:PostalAddress
      name:Ziekenhuisnetwerk Antwerpen-Middelheim
      address:
         name:Ziekenhuisnetwerk Antwerpen-Middelheim, Antwerp, Belgium
         type:PostalAddress
      name:FGU Hertzen Oncology Research Institute of Rosmedtechnology
      address:
         name:FGU Hertzen Oncology Research Institute of Rosmedtechnology, Moscow, Russia
         type:PostalAddress
      name:Federal Agency for High Technology Medical Care
      address:
         name:Russian Scientific Center of Radiology and Surgical Technologies, Federal Agency for High Technology Medical Care, St. Petersburg, Russia
         type:PostalAddress
      name:University of Southampton Faculty of Medicine
      address:
         name:University of Southampton Faculty of Medicine, Southampton, UK
         type:PostalAddress
      name:Janssen Research & Development
      address:
         name:Janssen Research & Development, Spring House, USA
         type:PostalAddress
      name:Janssen Research & Development
      address:
         name:Janssen Research & Development, Radnor, USA
         type:PostalAddress
      name:Janssen Research & Development
      address:
         name:Janssen Research & Development, Spring House, USA
         type:PostalAddress
      name:Janssen Research & Development
      address:
         name:Janssen Research & Development, Radnor, USA
         type:PostalAddress
      name:Janssen Research & Development
      address:
         name:Janssen Research & Development, Raritan, USA
         type:PostalAddress
      name:Janssen Research & Development
      address:
         name:Janssen Research & Development, Raritan, USA
         type:PostalAddress
      name:NHS Foundation Trust and the Institute of Cancer Research
      address:
         name:Royal Marsden, NHS Foundation Trust and the Institute of Cancer Research, Sutton, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Kenneth J. Pienta
      affiliation:
            name:University of Michigan Comprehensive Cancer Center
            address:
               name:University of Michigan Comprehensive Cancer Center, Ann Arbor, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Jean-Pascal Machiels
      affiliation:
            name:Université catholique de Louvain
            address:
               name:Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Dirk Schrijvers
      affiliation:
            name:Ziekenhuisnetwerk Antwerpen-Middelheim
            address:
               name:Ziekenhuisnetwerk Antwerpen-Middelheim, Antwerp, Belgium
               type:PostalAddress
            type:Organization
      name:Boris Alekseev
      affiliation:
            name:FGU Hertzen Oncology Research Institute of Rosmedtechnology
            address:
               name:FGU Hertzen Oncology Research Institute of Rosmedtechnology, Moscow, Russia
               type:PostalAddress
            type:Organization
      name:Mikhail Shkolnik
      affiliation:
            name:Federal Agency for High Technology Medical Care
            address:
               name:Russian Scientific Center of Radiology and Surgical Technologies, Federal Agency for High Technology Medical Care, St. Petersburg, Russia
               type:PostalAddress
            type:Organization
      name:Simon J. Crabb
      affiliation:
            name:University of Southampton Faculty of Medicine
            address:
               name:University of Southampton Faculty of Medicine, Southampton, UK
               type:PostalAddress
            type:Organization
      name:Susan Li
      affiliation:
            name:Janssen Research & Development
            address:
               name:Janssen Research & Development, Spring House, USA
               type:PostalAddress
            type:Organization
      name:Shobha Seetharam
      affiliation:
            name:Janssen Research & Development
            address:
               name:Janssen Research & Development, Radnor, USA
               type:PostalAddress
            type:Organization
      name:Thomas A. Puchalski
      affiliation:
            name:Janssen Research & Development
            address:
               name:Janssen Research & Development, Spring House, USA
               type:PostalAddress
            type:Organization
      name:Chris Takimoto
      affiliation:
            name:Janssen Research & Development
            address:
               name:Janssen Research & Development, Radnor, USA
               type:PostalAddress
            type:Organization
      name:Yusri Elsayed
      affiliation:
            name:Janssen Research & Development
            address:
               name:Janssen Research & Development, Raritan, USA
               type:PostalAddress
            type:Organization
      name:Fitzroy Dawkins
      affiliation:
            name:Janssen Research & Development
            address:
               name:Janssen Research & Development, Raritan, USA
               type:PostalAddress
            type:Organization
      name:Johann S. de Bono
      affiliation:
            name:NHS Foundation Trust and the Institute of Cancer Research
            address:
               name:Royal Marsden, NHS Foundation Trust and the Institute of Cancer Research, Sutton, UK
               type:PostalAddress
            type:Organization
PostalAddress:
      name:University of Michigan Comprehensive Cancer Center, Ann Arbor, USA
      name:Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium
      name:Ziekenhuisnetwerk Antwerpen-Middelheim, Antwerp, Belgium
      name:FGU Hertzen Oncology Research Institute of Rosmedtechnology, Moscow, Russia
      name:Russian Scientific Center of Radiology and Surgical Technologies, Federal Agency for High Technology Medical Care, St. Petersburg, Russia
      name:University of Southampton Faculty of Medicine, Southampton, UK
      name:Janssen Research & Development, Spring House, USA
      name:Janssen Research & Development, Radnor, USA
      name:Janssen Research & Development, Spring House, USA
      name:Janssen Research & Development, Radnor, USA
      name:Janssen Research & Development, Raritan, USA
      name:Janssen Research & Development, Raritan, USA
      name:Royal Marsden, NHS Foundation Trust and the Institute of Cancer Research, Sutton, UK
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(115)

• How much does https://www.springernature.com/gp/authors generate monthly?
• Income figures for https://link.springernature.com/home/
• Learn how profitable https://order.springer.com/public/cart is on a monthly basis
• How much does https://submission.nature.com/new-submission/10637/3 gross monthly?
• Get to know https://www.springernature.com/gp/librarians/licensing/agc/journals's earnings
• What's the monthly income of https://doi.org/10.3322%2Fcaac.20138?
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22237781's gross income?
• Income figures for http://scholar.google.com/scholar_lookup?&title=Cancer%20statistics%2C%202012&journal=CA%20Cancer%20J%20Clin&doi=10.3322%2Fcaac.20138&volume=62&pages=10-29&publication_year=2012&author=Siegel%2CR&author=Naishadham%2CD&author=Jemal%2CA
• How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17290734 have?
• How much does http://scholar.google.com/scholar_lookup?&title=Prostate%20cancer%3A%20a%20practical%20approach%20to%20current%20management%20of%20recurrent%20disease&journal=Mayo%20Clin%20Proc&volume=82&pages=243-249&publication_year=2007&author=Walczak%2CJR&author=Carducci%2CMA generate monthly?
• How much does https://doi.org/10.1002%2Fjcb.21220 gross monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17216598 earn?
• What's the income of http://scholar.google.com/scholar_lookup?&title=CCR2%20expression%20correlates%20with%20prostate%20cancer%20progression&journal=J%20Cell%20Biochem&doi=10.1002%2Fjcb.21220&volume=101&pages=676-685&publication_year=2007&author=Lu%2CY&author=Cai%2CZ&author=Xiao%2CG?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18347563 generate monthly?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Second-line%20chemotherapy%20for%20advanced%20hormone-refractory%20prostate%20cancer&journal=Clin%20Adv%20Hematol%20Oncol&volume=6&pages=118-132&publication_year=2008&author=Garmey%2CEG&author=Sartor%2CO&author=Halabi%2CS&author=Vogelzang%2CNJ?
• What's the total monthly financial gain of https://doi.org/10.1056%2FNEJMoa040720?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15470213 generate monthly?
• http://scholar.google.com/scholar_lookup?&title=Docetaxel%20plus%20prednisone%20or%20mitoxantrone%20plus%20prednisone%20for%20advanced%20prostate%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa040720&volume=351&pages=1502-1512&publication_year=2004&author=Tannock%2CIF&author=Wit%2CR&author=Berry%2CWR income
• How much cash flow does https://doi.org/10.1200%2FJCO.2007.12.4008 have monthly?
• What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18182665 each month?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Docetaxel%20plus%20prednisone%20or%20mitoxantrone%20plus%20prednisone%20for%20advanced%20prostate%20cancer%3A%20updated%20survival%20in%20the%20TAX%20327%20study&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2007.12.4008&volume=26&pages=242-245&publication_year=2008&author=Berthold%2CDR&author=Pond%2CGR&author=Soban%2CF&author=Wit%2CR&author=Eisenberger%2CM&author=Tannock%2CIF
• What's the monthly money flow for https://doi.org/10.1056%2FNEJMoa1014618?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21612468 earn?
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=Abiraterone%20and%20increased%20survival%20in%20metastatic%20prostate%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1014618&volume=364&pages=1995-2005&publication_year=2011&author=Bono%2CJS&author=Logothetis%2CCJ&author=Molina%2CA each month?
• Profit of https://doi.org/10.1016%2FS0140-6736%2810%2961389-X
• What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20888992?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Prednisone%20plus%20cabazitaxel%20or%20mitoxantrone%20for%20metastatic%20castration-resistant%20prostate%20cancer%20progressing%20after%20docetaxel%20treatment%3A%20a%20randomised%20open-label%20trial&journal=Lancet&doi=10.1016%2FS0140-6736%2810%2961389-X&volume=376&pages=1147-1154&publication_year=2010&author=Bono%2CJS&author=Oudard%2CS&author=Ozguroglu%2CM
• Financial intake of https://doi.org/10.1002%2Fpros.20464
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16705739?
• How much does http://scholar.google.com/scholar_lookup?&title=Monocyte%20chemotactic%20protein-1%20%28MCP-1%29%20acts%20as%20a%20paracrine%20and%20autocrine%20factor%20for%20prostate%20cancer%20growth%20and%20invasion&journal=Prostate&doi=10.1002%2Fpros.20464&volume=66&pages=1311-1318&publication_year=2006&author=Lu%2CY&author=Cai%2CZ&author=Galson%2CDL pull in monthly?
• Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8701989
• Get to know http://scholar.google.com/scholar_lookup?&title=Monocyte%20chemoattractant%20protein-1%20gene%20expression%20in%20prostatic%20hyperplasia%20and%20prostate%20adenocarcinoma&journal=Am%20J%20Pathol&volume=149&pages=501-509&publication_year=1996&author=Mazzucchelli%2CL&author=Loetscher%2CP&author=Kappeler%2CA's earnings
• Find out how much https://doi.org/10.1002%2Fijc.22704 earns monthly
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17390372 pull in monthly?
• Profit of http://scholar.google.com/scholar_lookup?&title=PTHrP-induced%20MCP-1%20production%20by%20human%20bone%20marrow%20endothelial%20cells%20and%20osteoblasts%20promotes%20osteoclast%20differentiation%20and%20prostate%20cancer%20cell%20proliferation%20and%20invasion%20in%20vitro&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.22704&volume=121&pages=724-733&publication_year=2007&author=Lu%2CY&author=Xiao%2CG&author=Galson%2CDL
• Revenue of https://doi.org/10.1593%2Fneo.06280
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16867220's gross income?
• Profit of http://scholar.google.com/scholar_lookup?&title=CCL2%20is%20a%20potent%20regulator%20of%20prostate%20cancer%20cell%20migration%20and%20proliferation&journal=Neoplasia&doi=10.1593%2Fneo.06280&volume=8&pages=578-586&publication_year=2006&author=Loberg%2CRD&author=Day%2CLL&author=Harwood%2CJ
• What's the profit of https://doi.org/10.1158%2F0008-5472.CAN-08-2164?
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19176388 generate?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=A%20destructive%20cascade%20mediated%20by%20CCL2%20facilitates%20prostate%20cancer%20growth%20in%20bone&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-08-2164&volume=69&pages=1685-1692&publication_year=2009&author=Li%2CX&author=Loberg%2CR&author=Liao%2CJ
• Profit of https://doi.org/10.1593%2Fneo.07307
• What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17710158?
• What's the income of http://scholar.google.com/scholar_lookup?&title=CCL2%20as%20an%20important%20mediator%20of%20prostate%20cancer%20growth%20in%20vivo%20through%20the%20regulation%20of%20macrophage%20infiltration&journal=Neoplasia&doi=10.1593%2Fneo.07307&volume=9&pages=556-562&publication_year=2007&author=Loberg%2CRD&author=Ying%2CC&author=Craig%2CM&author=Yan%2CL&author=Snyder%2CLA&author=Pienta%2CKJ?
• Explore the financials of https://doi.org/10.1158%2F0008-5472.CAN-07-1286
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17909051's financial summary
• How much does http://scholar.google.com/scholar_lookup?&title=Targeting%20CCL2%20with%20systemic%20delivery%20of%20neutralizing%20antibodies%20induces%20prostate%20cancer%20tumor%20regression%20in%20vivo&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-07-1286&volume=67&pages=9417-9424&publication_year=2007&author=Loberg%2CRD&author=Ying%2CC&author=Craig%2CM rake in every month?
• See how much http://scholar.google.com/scholar_lookup?&title=First-in-human%2C%20first-in-class%2C%20phase%20I%20study%20of%20a%20human%20monoclonal%20antibody%20CNTO%20888%20to%20the%20CC-chemokine%20ligand%202%20%28CCL2%2FMCP-1%29%20in%20patients%20with%20solid%20tumors&journal=J%20Clin%20Oncol&volume=27&publication_year=2009&author=Sandhu%2CSK&author=Fong%2CPC&author=Frentzas%2CS makes per month
• https://doi.org/10.1016%2Fj.ejca.2008.10.026's financial summary
• What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19097774?
• How much money does http://scholar.google.com/scholar_lookup?&title=New%20response%20evaluation%20criteria%20in%20solid%20tumours%3A%20revised%20RECIST%20guideline%20%28version%201.1%29&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2008.10.026&volume=45&pages=228-247&publication_year=2009&author=Eisenhauer%2CEA&author=Therasse%2CP&author=Bogaerts%2CJ generate?
• What's the profit of https://doi.org/10.1200%2FJCO.2007.12.4487?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18309951 bring in each month?
• How much does http://scholar.google.com/scholar_lookup?&title=Design%20and%20end%20points%20of%20clinical%20trials%20for%20patients%20with%20progressive%20prostate%20cancer%20and%20castrate%20levels%20of%20testosterone%3A%20recommendations%20of%20the%20Prostate%20Cancer%20Clinical%20Trials%20Working%20Group&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2007.12.4487&volume=26&pages=1148-1159&publication_year=2008&author=Scher%2CHI&author=Halabi%2CS&author=Tannock%2CI earn?
• https://doi.org/10.1158%2F1078-0432.CCR-06-0988's financial summary
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17062707?
• How much does http://scholar.google.com/scholar_lookup?&title=The%20measurement%20of%20pain%20from%20metastatic%20bone%20disease%3A%20capturing%20the%20patient%E2%80%99s%20experience&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-06-0988&volume=12&pages=6236s-6242s&publication_year=2006&author=Cleeland%2CCS pull in monthly?
• Earnings of https://doi.org/10.1200%2FJCO.2007.15.0367
• Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18487572
• How much profit is http://scholar.google.com/scholar_lookup?&title=Pain%20predicts%20overall%20survival%20in%20men%20with%20metastatic%20castration-refractory%20prostate%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2007.15.0367&volume=26&pages=2544-2549&publication_year=2008&author=Halabi%2CS&author=Vogelzang%2CNJ&author=Kornblith%2CAB making per month?
• What's the revenue for https://doi.org/10.1158%2F1078-0432.CCR-07-1506?
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18056182
• How much profit does http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20cell%20number%20and%20prognosis%20in%20progressive%20castration-resistant%20prostate%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-1506&volume=13&pages=7053-7058&publication_year=2007&author=Danila%2CDC&author=Heller%2CG&author=Gignac%2CGA generate?
• Financial intake of https://doi.org/10.1158%2F1078-0432.CCR-08-0872
• Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18829513
• How much money does http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20cells%20predict%20survival%20benefit%20from%20treatment%20in%20metastatic%20castration-resistant%20prostate%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-08-0872&volume=14&pages=6302-6309&publication_year=2008&author=Bono%2CJS&author=Scher%2CHI&author=Montgomery%2CRB make?
• What's the financial gain of https://doi.org/10.1002%2Fart.21975?
• What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16869001?
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=A%20randomized%20controlled%20trial%20with%20an%20anti-CCL2%20%28anti-monocyte%20chemotactic%20protein%201%29%20monoclonal%20antibody%20in%20patients%20with%20rheumatoid%20arthritis&journal=Arthritis%20Rheum&doi=10.1002%2Fart.21975&volume=54&pages=2387-2392&publication_year=2006&author=Haringman%2CJJ&author=Gerlag%2CDM&author=Smeets%2CTJ each month?
• How much does http://scholar.google.com/scholar_lookup?&title=Utilizing%20mechanistic%20PK%2FPD%20modeling%20to%20simultaneously%20examine%20free%20CCL2%2C%20total%20CCL2%2C%20and%20CNTO%20888%20serum%20concentration%20time%20data&journal=J%20Clin%20Oncol&volume=28&publication_year=2010&author=Fetterly%2CGJ&author=Puchalski%2CT&author=Takimoto%2CC pull in monthly?
• What's the monthly income of https://citation-needed.springer.com/v2/references/10.1007/s10637-012-9869-8?format=refman&flavour=references?
• What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kenneth%20J.%20Pienta?
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kenneth%20J.%20Pienta%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
• How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jean-Pascal%20Machiels?
• Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jean-Pascal%20Machiels%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
• How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Dirk%20Schrijvers earning monthly?
• See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Dirk%20Schrijvers%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
• Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Boris%20Alekseev
• Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Boris%20Alekseev%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mikhail%20Shkolnik makes per month
• Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mikhail%20Shkolnik%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Simon%20J.%20Crabb have?
• Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Simon%20J.%20Crabb%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Susan%20Li pull in monthly?
• Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Susan%20Li%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shobha%20Seetharam generate monthly?
• How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shobha%20Seetharam%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
• Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Thomas%20A.%20Puchalski
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Thomas%20A.%20Puchalski%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
• How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chris%20Takimoto generate?
• How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chris%20Takimoto%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yusri%20Elsayed
• Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yusri%20Elsayed%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Fitzroy%20Dawkins
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Fitzroy%20Dawkins%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Johann%20S.%20de%20Bono rake in every month?
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Johann%20S.%20de%20Bono%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
• How much money does https://s100.copyright.com/AppDispatchServlet?title=Phase%202%20study%20of%20carlumab%20%28CNTO%20888%29%2C%20a%20human%20monoclonal%20antibody%20against%20CC-chemokine%20ligand%202%20%28CCL2%29%2C%20in%20metastatic%20castration-resistant%20prostate%20cancer&author=Kenneth%20J.%20Pienta%20et%20al&contentID=10.1007%2Fs10637-012-9869-8©right=Springer%20Science%2BBusiness%20Media%2C%20LLC&publication=0167-6997&publicationDate=2012-08-21&publisherName=SpringerNature&orderBeanReset=true make?
• How much revenue does https://citation-needed.springer.com/v2/references/10.1007/s10637-012-9869-8?format=refman&flavour=citation generate?
• Get to know https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral's earnings
• Get to know https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research's earnings
• Earnings of https://www.springernature.com/gp/products
• How much cash flow does https://www.springernature.com/gp/librarians have monthly?
• How much does https://www.springernature.com/gp/societies net monthly?
• How much money does https://www.springernature.com/gp/partners generate?
• Monthly income for https://www.springer.com/
• Earnings of https://www.nature.com/
• What are the total earnings of https://www.biomedcentral.com/?
• What's the total monthly financial gain of https://www.palgrave.com/?
• How much income does https://www.apress.com/ have?
• How much income does https://www.springernature.com/gp/legal/ccpa have?
• Explore the financials of https://www.springernature.com/gp/info/accessibility
• How much does https://support.springernature.com/en/support/home net monthly?
• How much cash flow does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations have monthly?
• What's the total monthly financial gain of https://www.springernature.com/?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref